Systemic immune‐inflammation index could estimate the cross‐sectional high activity and the poor outcomes in immunosuppressive drug‐naïve patients with antineutrophil cytoplasmic antibody‐associated vasculitis
- 11 September 2018
- journal article
- research article
- Published by Wiley in Nephrology
- Vol. 24 (7) , 711-717
Abstract
Objectives: We investigated whether systemic immune‐inflammation index (SII) at diagnosis can estimate the cross‐sectional high activity and predict the poor outcomes in immunosuppressive drug‐naïve patients with antineutrophil cytoplasmic antibody‐associated vasculitis (AAV).Methods: We retrospectively reviewed the medical records of 163 patients with AAV and obtained clinical and laboratory data. We calculated Birmingham vasculitis activity score (BVAS) as well as five‐factor score (FFS) (2009) at diagnosis. SII at diagnosis was calculated by the equation of (SII at diagnosis = platelet count × neutrophil count/lymphocyte count at diagnosis). Severe AAV was defined as BVAS at diagnosis ≥16. The odds ratio was assessed using the multivariable logistic regression analysis and cumulative survival rates were compared by the Kaplan–Meier survival analysis.Results: The median age at diagnosis was 58.0 years old and 51 patients were men. The median BVAS was 12.0. Fifty‐seven patients had severe AAV. The median SII at diagnosis was 1349.6. In the multivariable analysis, only SII exhibited a significant odds ratio for the cross‐sectional severe AAV (P = 0.043). We obtained the cut‐off of SII at diagnosis for severe AAV as 1573.56. Patients with SII at diagnosis ≥1573.56 exhibited a significantly high relative risk of the cross‐sectional severe AAV compared to those without (relative risk 4.625). Furthermore, patients with SII at diagnosis ≥1573.56 exhibited significantly the lower cumulative relapse free and renal survivals than those without.Conclusion: Systemic immune‐inflammation index at diagnosis could estimate the cross‐section severe AAV and predict the poor outcomes in AAV patients.Keywords
Funding Information
- Yonsei University College of Medicine (6‐2016‐0145)
This publication has 24 references indexed in Scilit:
- Systemic immune-inflammation index in germ-cell tumoursBritish Journal of Cancer, 2018
- Lymphopenia and autoimmunity: A double-edged swordHuman Immunology, 2016
- Current and emerging techniques for ANCA detection in vasculitisNature Reviews Rheumatology, 2014
- Inhibition of human neutrophil activity by an RNA aptamer bound to interleukin-8Biomaterials, 2014
- Neutrophil recruitment and function in health and inflammationNature Reviews Immunology, 2013
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesArthritis & Rheumatism, 2012
- Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitidesNature Clinical Practice Rheumatology, 2006
- A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity ScoreArthritis & Rheumatism, 2001
- The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosisArthritis & Rheumatism, 1990
- The American College of Rheumatology 1990 criteria for the classification of churg‐strauss syndrome (allergic granulomatosis and angiitis)Arthritis & Rheumatism, 1990